SynOx Therapeutics
0 followers
SynOx Therapeutics Ltd was founded in November 2020 and is solely focused on developing emactuzumab for the treatment of diffuse tenosynovial giant cell tumours (TGCT) and other indications. SynOx is backed by a strong investor syndicate with long and successful backgrounds in building biopharma com... Read more
Org chart
Raymond Barlow
Chief Executive Officer
Raymond Barlow
Collapse
Broes Naeye
Chief Technology Officer
Hamina Patel
Chief Medical Officer
Sarah Clare
Svp, Finance And Operations
Sander Veltkamp
Vp, External Affairs And Business Development
Frank Bracken
Senior Vice President Of Quality
